34 results on '"Rathore, Richa"'
Search Results
2. #36. Novel therapeutic development with serine biosynthesis inhibition and molecularly targeted drugs against the aggressive osteosarcoma
3. #18. Inhibition of de novo serine synthesis in osteosarcoma depletes cysteine and drives dependency upon exogenous cystine import through system xCT to maintain redox balance
4. Developing a Metabolic Therapy for Osteosarcoma
5. Systems level profiling of arginine starvation reveals MYC and ERK adaptive metabolic reprogramming
6. Cisplatin exposure causes c-Myc-dependent resistance to CDK4/6 inhibition in HPV-negative head and neck squamous cell carcinoma
7. Feasibility of personalized circulating tumor DNA detection in stage II and III melanoma
8. Supplementary Data from Malic Enzyme 1 Absence in Synovial Sarcoma Shifts Antioxidant System Dependence and Increases Sensitivity to Ferroptosis Induction with ACXT-3102
9. Supplementary Figure from Malic Enzyme 1 Absence in Synovial Sarcoma Shifts Antioxidant System Dependence and Increases Sensitivity to Ferroptosis Induction with ACXT-3102
10. Supplementary Data from Arginine Starvation and Docetaxel Induce c-Myc–Driven hENT1 Surface Expression to Overcome Gemcitabine Resistance in ASS1-Negative Tumors
11. Supplementary Table from Malic Enzyme 1 Absence in Synovial Sarcoma Shifts Antioxidant System Dependence and Increases Sensitivity to Ferroptosis Induction with ACXT-3102
12. Feasibility of Longitudinal ctDNA Assessment in Patients with Uterine and Extra-Uterine Leiomyosarcoma
13. Circulating Tumor DNA As a Biomarker for Molecular Residual Disease Assessment in Patients with Diffuse Large B-Cell Lymphoma
14. Utility of a circulating tumor DNA test for detecting clinically evident and occult Merkel cell carcinoma
15. Clinical utility of circulating tumor DNA in patients with head and neck cancers.
16. Use of circulating tumor DNA in newly diagnosed DLBCL patients.
17. The relationship between circulating tumor DNA with Merkel cell carcinoma tumor burden and detection of recurrence.
18. Malic Enzyme 1 Absence in Synovial Sarcoma Shifts Antioxidant System Dependence and Increases Sensitivity to Ferroptosis Induction with ACXT-3102
19. Abstract 12572: Low Incidence of Cardiovascular Events in Patients With Metastatic Sarcoma Using Upfront Dexrazoxane and High-Dose Doxorubicin
20. Feasibility of Longitudinal ctDNA Assessment in Patients with Uterine and Extra-Uterine Leiomyosarcoma.
21. Targeting the PHGDH-mTOR Metabolic Axis in Osteosarcoma
22. Interim Analysis of the Phase II Study: Noninferiority Study of Doxorubicin with Upfront Dexrazoxane plus Olaratumab for Advanced or Metastatic Soft-Tissue Sarcoma
23. Targeting one-carbon metabolism requires mTOR inhibition: a new therapeutic approach in osteosarcoma
24. Pathogenesis and Current Treatment of Osteosarcoma: Perspectives for Future Therapies
25. Cucurbit[6]uril as a Fire Retardant Material
26. Systems level profiling of arginine starvation reveals MYC and ERK adaptive metabolic reprogramming
27. PHGDH as a mechanism for resistance in metabolically-driven cancers
28. Diagnosis and management of malignant peripheral nerve sheath tumors: Current practice and future perspectives
29. Arginine Starvation and Docetaxel Induce c-Myc–Driven hENT1 Surface Expression to Overcome Gemcitabine Resistance in ASS1-Negative Tumors
30. Abstract CT111: Preclinical justification for the Phase II clinical trial ADI-PEG 20 in combination with gemcitabine and docetaxel for the treatment of soft tissue sarcoma
31. Targeted delivery of gold nanoparticle contrast agents for reporting gene detection by magnetic resonance imaging
32. Targeted Inhibition of Snail Activity in Breast Cancer Cells by Using a CoIII‐Ebox Conjugate
33. Molecular residual disease (MRD) detection using bespoke circulating tumor DNA (ctDNA) assays in localized soft tissue sarcoma (STS).
34. Targeted Inhibition of Snail Activity in Breast Cancer Cells by Using a CoIII-Ebox Conjugate.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.